Top Markets
Coin of the day
Immunotech Laboratories, Inc. Immunotech Laboratories, Inc.

Immunotech Laboratories, Inc.

IMMB
Classement en actions #40594
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Prix de l'action
$0.0002
Dernière synchronisation: 2026-08-12
Capitalisation boursière
$114.99K
Changement (1 jour)
0.00%
Changement (1 an)
100.00%
Pays
US
Échange Immunotech Laboratories, Inc. (IMMB)

Catégorie

Historique du prix de l'action pour Immunotech Laboratories, Inc. (IMMB)
Prix de clôture le plus élevé : $0.00 le 2026-08-01

Prix de clôture le plus bas : $0.00 le 2022-03-01
Historique du prix de l'action de Immunotech Laboratories, Inc. de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -40.00%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE